ZELIRA
LIVE

Serial Number

79280774

Owner

Zelira Therapeutics Limited

Attorney

Elizabeth M. O'Donoghue

Filing Date

Jan 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ZELIRA Trademark

Serial Number: 79280774 • Registration: 6655611

ZELIRA is a trademark filed by Zelira Therapeutics Limited on January 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Zelira Therapeutics Limited (8 trademarks)

Level 26, 140 St Georges Terrace
Perth WA6000 , AU

Entity Type: 99

Trademark Details

Filing Date

January 9, 2020

Registration Date

March 1, 2022

Published for Opposition

December 14, 2021

Goods & Services

Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of Alpha-One proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections

Conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, namely, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of Alpha-One proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 2, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 2, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 1, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 1, 2022 R.PR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Feb 2, 2022 LIME
NOTIFICATION PROCESSED BY IB
Dec 19, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 14, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 24, 2021 NONP
LIMITATION OF GOODS RECEIVED FROM IB
Nov 21, 2021 LIMG
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 21, 2021 ADCH
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2021 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 4, 2021 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 4, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 18, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 18, 2021 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 29, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 29, 2021 GNSL
SUSPENSION LETTER WRITTEN
Apr 29, 2021 CNSL
ATTORNEY REVIEW COMPLETED
Apr 19, 2021 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Mar 24, 2021 LIME
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2021 TROA
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Mar 22, 2021 LIME
NEW REPRESENTATIVE AT IB RECEIVED
Jan 2, 2021 NREP
LIMITATION OF GOODS RECEIVED FROM IB
Dec 4, 2020 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Nov 7, 2020 LIMG
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 3, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 3, 2020 COAR
REFUSAL PROCESSED BY IB
Oct 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 22, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2020 DOCK
ASSIGNED TO EXAMINER
Mar 29, 2020 DOCK
ASSIGNED TO EXAMINER
Mar 27, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 20, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2020 REPR